Premium-First Healthcare Market Expansion
Win discerning consumers first, then use evidence and scale to expand access
- Difficulty
- Expert
- Time to result
- ~ongoing to results
- Steps
- 6
- Confidence
- 94%
Premium-first expansion begins outside the traditional three-party healthcare system with a direct-to-consumer offering for motivated customers willing to pay for access and experience. These discerning users impose a high product-quality bar while generating revenue, feedback, and evidence about effectiveness. The company then uses growing demand to improve purchasing power, stimulate hardware or regulatory innovation, and reduce unit costs. Only after establishing a strong consumer product does it move toward employers, insurers, or other enterprise channels. Working in this direction prevents the initial experience from being optimized merely for billing codes and organizational purchasers. The long-term objective is not permanent exclusivity but a staged descent from a scarce premium product toward a scalable, affordable offering.
Origin
Clemente described Levels as being in a Tesla Roadster-like phase: an expensive, constrained product intended to establish the economic and experiential foundation for moving down-market.
Core principles
- 01Start where customers can choose and pay directly
- 02Use demanding early customers to force a superior experience
- 03Generate evidence before approaching institutional buyers
- 04Let volume and innovation improve unit economics
- 05Expand down-market without designing the first product around reimbursement
How to run it
- 1
Choose the premium wedge
Identify customers who feel the problem strongly enough to pay directly for a scarce or expensive early solution.
Pro tip Target motivation and urgency rather than broad demographic appeal.
Watch out Do not mistake affluent curiosity for durable customer value.
- 2
Package the complete experience
Integrate product access, regulatory steps, fulfillment, software, and education so the user experiences one coherent service.
Pro tip Hide avoidable operational complexity without concealing required medical judgment.
Watch out Convenience must not compromise regulatory independence or safety.
- 3
Satisfy discerning users
Use premium customers' expectations to develop an exceptional product and responsive feedback loop.
Pro tip Measure sustained behavior and retention, not just initial demand.
Watch out A high price cannot compensate for weak outcomes indefinitely.
- 4
Generate credible evidence
Collect consented usage, outcome, and effectiveness data that can demonstrate value beyond anecdotes.
Pro tip Separate commercial decisions from independent clinical judgment.
Watch out Protect privacy and avoid claiming therapeutic efficacy before approval.
- 5
Improve the economics
Use volume, supplier negotiation, software intelligence, hardware innovation, and regulatory progress to lower delivery costs.
Pro tip Track which cost reductions genuinely increase access rather than only margin.
Watch out Do not assume hardware prices will fall without active market development.
- 6
Move down-market
Introduce lower-cost or reimbursed offerings while retaining the experience learned from premium consumers.
Pro tip Treat the consumer product as the quality reference for enterprise versions.
Watch out Institutional purchasing incentives can pull the product back toward conformity.
In the wild
Levels offered an invitation-only, one-month program combining a physician-reviewed prescription pathway, CGM fulfillment, software, and education. Roughly 7,000 people had completed the beta while about 105,000 remained on the wait list, giving the company demand evidence and a base for improving the product before wider expansion.
→ The premium wedge produced consumer feedback, revenue, and a large non-diabetic glucose dataset while the company pursued lower-cost access.
A startup launches a costly biomarker-coaching service for highly motivated cash-pay customers. It uses their feedback to refine the experience, validates improved adherence, negotiates lower lab costs at higher volume, and later offers an employer-sponsored version based on the same consumer-quality workflow.
→ The company reaches institutional buyers with evidence and a tested experience rather than designing for reimbursement from day one.
Common mistakes
Designing for the buyer, not the user
Starting with reimbursement or enterprise procurement can produce a sellable product that patients do not value or continue using.
Treating premium as the destination
The early high price is a staging mechanism; failing to improve economics leaves the people with greatest need excluded.
Expanding before proving value
Moving into mass-market or payer channels before demonstrating outcomes and usability scales weaknesses rather than advantages.
Is it for you?
Best for
It is best for products with immediate consumer value, regulatory complexity, high initial costs, and a plausible path to better economics through scale.
Not ideal for
It is not ideal for emergency treatments, products whose risks demand intensive clinical supervision, or markets without a motivated cash-pay segment.
From the transcript
“If we just design something for B2B, you know, reimbursal, we we fall into the same trap that so many other products have that you…”
“So by working backwards, not only will we be able to demonstrate with the the data we're generating from our paying customers that this is…”
“But if we can satisfy the roadster crowd, we can then take that success and the sort of economic foundation that we build through a…”
From the episode
Special: "Why Now" for Digital Health (with Levels founder Josh Clemente)
Josh Clemente